CL2019001750A1 - Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas. - Google Patents
Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas.Info
- Publication number
- CL2019001750A1 CL2019001750A1 CL2019001750A CL2019001750A CL2019001750A1 CL 2019001750 A1 CL2019001750 A1 CL 2019001750A1 CL 2019001750 A CL2019001750 A CL 2019001750A CL 2019001750 A CL2019001750 A CL 2019001750A CL 2019001750 A1 CL2019001750 A1 CL 2019001750A1
- Authority
- CL
- Chile
- Prior art keywords
- disease
- protein aggregation
- french
- modulators
- heteroaryl derivatives
- Prior art date
Links
- 230000004845 protein aggregation Effects 0.000 title abstract 2
- 125000003545 alkoxy group Chemical group 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 208000018737 Parkinson disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000001089 Multiple system atrophy Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A CIERTOS COMPUESTOS DE BISHETEROARILO, A LAS COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y A LOS MÉTODOS PARA USARLOS, INCLUIDOS LOS MÉTODOS PARA PREVENIR, REVERTIR, DESACELERAR O INHIBIR LA AGREGACIÓN DE PROTEÍNAS, Y A LOS MÉTODOS PARA TRATAR ENFERMEDADES QUE ESTÁN ASOCIADAS CON LA AGREGACIÓN DE PROTEÍNAS, INCLUYENDO LAS ENFERMEDADES NEURODEGENERATIVAS TALES COMO LA ENFERMEDAD DE PARKINSON, LA ENFERMEDAD DE ALZHEIMER, LA ENFERMEDAD DE LOS CUERPOS DE LEWY, LA ENFERMEDAD DE PARKINSON CON DEMENCIA, LA DEMENCIA FRONTO-TEMPORAL, LA ENFERMEDAD DE HUNTINGTON, LA ESCLEROSIS LATERAL AMIOTRÓFICA, LA ATROFIA MULTISISTÉMICA Y EL CÁNCER, INCLUIDO EL MELANOMA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17153210 | 2017-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2019001750A1 true CL2019001750A1 (es) | 2019-11-22 |
Family
ID=57906525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019001750A CL2019001750A1 (es) | 2017-01-26 | 2019-06-21 | Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11091474B2 (es) |
| EP (1) | EP3573981B1 (es) |
| JP (1) | JP7100042B2 (es) |
| KR (1) | KR20190112031A (es) |
| CN (1) | CN110191885B (es) |
| AU (1) | AU2018213886A1 (es) |
| BR (1) | BR112019011931A2 (es) |
| CL (1) | CL2019001750A1 (es) |
| CO (1) | CO2019007833A2 (es) |
| EA (1) | EA201991753A1 (es) |
| ES (1) | ES2918048T3 (es) |
| IL (1) | IL268003A (es) |
| MA (1) | MA47369A (es) |
| MX (1) | MX2019007054A (es) |
| RU (1) | RU2019126164A (es) |
| WO (1) | WO2018138085A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019011932A2 (pt) * | 2017-01-26 | 2019-10-29 | Ucb Biopharma Sprl | derivados de bis-heteroarila como moduladores da agregação de proteína |
| CN113214289B (zh) * | 2020-01-21 | 2022-10-28 | 瀚远医药有限公司 | 5-ht2a受体拮抗剂及其治疗中枢神经系统疾病的应用 |
| CN118488951A (zh) * | 2021-12-27 | 2024-08-13 | 上海京新生物医药有限公司 | 作为蛋白质聚集抑制剂的稠合双环杂芳基酰胺化合物 |
| WO2025002040A1 (zh) * | 2023-06-25 | 2025-01-02 | 上海京新生物医药有限公司 | 双环杂芳基酰胺化合物的晶型及盐、制备方法和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| EP2513090A1 (en) | 2009-12-16 | 2012-10-24 | Neuropore Therapies, Inc. | Compound suitable for the treatment of synucleopathies |
| GB201021103D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | New compounds for the treatment of neurodegenerative diseases |
| WO2013134371A1 (en) | 2012-03-06 | 2013-09-12 | Neuropore Therapies, Inc. | Methods and compounds to be used in the treatment of neurodegenerative diseases |
| NZ631388A (en) | 2012-03-28 | 2016-01-29 | Neuropore Therapies Inc | Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation |
| KR20150031481A (ko) | 2012-07-16 | 2015-03-24 | 뉴로포레 테라피스, 인코포레이티드 | 단백질 응집 저해제로서의 디- 및 트리-헤테로아릴 유도체 |
| RS57533B1 (sr) * | 2014-01-29 | 2018-10-31 | Ucb Biopharma Sprl | Heteroaril amidi kao inhibitori proteinske agregacije |
| WO2017020010A1 (en) | 2015-07-29 | 2017-02-02 | Neuropore Therapies, Inc. | Bis-heteroaryl derivatives as modulators of protein aggregation |
| BR112019011932A2 (pt) * | 2017-01-26 | 2019-10-29 | Ucb Biopharma Sprl | derivados de bis-heteroarila como moduladores da agregação de proteína |
| ES2884145T3 (es) * | 2017-01-26 | 2021-12-10 | UCB Biopharma SRL | Derivados bicíclicos de bis-heteroarilo como moduladores de la agregación de proteínas |
-
2018
- 2018-01-23 JP JP2019539261A patent/JP7100042B2/ja active Active
- 2018-01-23 ES ES18703235T patent/ES2918048T3/es active Active
- 2018-01-23 CN CN201880006709.9A patent/CN110191885B/zh active Active
- 2018-01-23 MX MX2019007054A patent/MX2019007054A/es unknown
- 2018-01-23 RU RU2019126164A patent/RU2019126164A/ru not_active Application Discontinuation
- 2018-01-23 EA EA201991753A patent/EA201991753A1/ru unknown
- 2018-01-23 AU AU2018213886A patent/AU2018213886A1/en not_active Abandoned
- 2018-01-23 KR KR1020197024618A patent/KR20190112031A/ko not_active Ceased
- 2018-01-23 MA MA047369A patent/MA47369A/fr unknown
- 2018-01-23 US US16/480,251 patent/US11091474B2/en active Active
- 2018-01-23 BR BR112019011931-0A patent/BR112019011931A2/pt not_active Application Discontinuation
- 2018-01-23 WO PCT/EP2018/051579 patent/WO2018138085A1/en not_active Ceased
- 2018-01-23 EP EP18703235.4A patent/EP3573981B1/en active Active
-
2019
- 2019-06-21 CL CL2019001750A patent/CL2019001750A1/es unknown
- 2019-07-11 IL IL268003A patent/IL268003A/en unknown
- 2019-07-22 CO CONC2019/0007833A patent/CO2019007833A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3573981A1 (en) | 2019-12-04 |
| EA201991753A1 (ru) | 2020-01-14 |
| RU2019126164A (ru) | 2021-02-26 |
| CA3048946A1 (en) | 2018-08-02 |
| WO2018138085A1 (en) | 2018-08-02 |
| MX2019007054A (es) | 2019-08-29 |
| MA47369A (fr) | 2019-12-04 |
| AU2018213886A1 (en) | 2019-07-25 |
| CO2019007833A2 (es) | 2019-08-20 |
| US11091474B2 (en) | 2021-08-17 |
| US20200291013A1 (en) | 2020-09-17 |
| EP3573981B1 (en) | 2022-03-16 |
| IL268003A (en) | 2019-09-26 |
| ES2918048T3 (es) | 2022-07-13 |
| JP7100042B2 (ja) | 2022-07-12 |
| BR112019011931A2 (pt) | 2019-10-29 |
| JP2020505368A (ja) | 2020-02-20 |
| CN110191885B (zh) | 2023-05-16 |
| CN110191885A (zh) | 2019-08-30 |
| KR20190112031A (ko) | 2019-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019007835A2 (es) | Derivados de bis-heteroarilo como moduladores de la agregación de proteínas | |
| CO2019007830A2 (es) | Derivados de bis-heteroarilo bicíclicos como moduladores de agregación de proteínas | |
| CR20160394A (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
| CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
| CL2019001744A1 (es) | Derivados de benzoxazol como inmunomoduladores. | |
| ECSP20033467A (es) | Compuestos macrocíclicos para tratar enfermedades | |
| CL2019001750A1 (es) | Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas. | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| UY36077A (es) | Derivados de 6-amino-8h-pteridin-7-ona como moduladores de ror gamma y composiciones farmacéuticas que los contienen | |
| GT201600147A (es) | Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2 | |
| CO2017012995A2 (es) | Derivados análogos de heteroarilos/arilo actvos como reguladores nrf2 y composiciones farmacéuticas de los mismos | |
| CU20170172A7 (es) | 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos | |
| CO2018009889A2 (es) | Moduladores alostéricos de receptores de acetilcolina nicotínicos | |
| MX369041B (es) | Proteinas quimericas tipo fosfatasa alcalina. | |
| CL2017003127A1 (es) | Derivados de 2,3-dihidro-4h-1,3-benzoxazin-4-ona como moduladores de receptor muscarinico m1 colinergico. | |
| CL2016002346A1 (es) | Composiciones para modular la expresión de ataxina 2 | |
| MX2015011533A (es) | Derivados de triazolona de piridinilo y piridinilo fusionado. | |
| EP3328379A4 (en) | BIS-HETEROARYL DERIVATIVES AS MODULATORS OF THE PROTEIN AGGREGATION | |
| DOP2017000117A (es) | 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
| CL2016002677A1 (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1. | |
| CL2017000244A1 (es) | Formulaciones de compuestos biológicos para instilación intravesical. | |
| CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
| MX2018007511A (es) | Compuestos de alquinil dihidroquinolina sulfonamida. | |
| MX2018007432A (es) | Compuestos de dihidroquinolinsulfonamida de alquilo. | |
| UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 |